PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

🧠 Clinical library

Clinical Specialty Index

626 articles indexed across 24 specialties, each reviewed by a licensed pharmacist before publication.

Showing 66 from 1 topic.Sort: Newest | Oldest
Hybrid Closed-Loop Therapy Raises Time in Range 10 Points in Preschoolers
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Moderate
Also in Pediatrics

Hybrid closed-loop systems enhance pediatric diabetes control safely.

Bihormonal Fully Closed-Loop System Raises Adolescent Time in Range by 13.6 Points
Analysis Pediatrics Hypothesis-generating Grade: Low
Also in Endocrinology / Diabetes / Obesity

Bihormonal closed-loop system boosts glucose control in teens with Type 1 diabetes.

Pharmacist-Embedded Liver Fibrosis Screening Finds Hidden Cirrhosis in Diabetes
Analysis Clinical Practice Hypothesis-generating Grade: Low
Also in Ambulatory Care / MTM, Endocrinology / Diabetes / Obesity

Pharmacists enhance liver disease detection in diabetes care.

Racial Gaps in Diabetes Adherence Persist Within Medicare Advantage Plans
★ Editor's Pick Analysis Ambulatory Care / MTM Confirmatory Grade: Moderate
Also in Endocrinology / Diabetes / Obesity

Medication adherence in diabetes shows racial and ethnic disparities.

Automated Insulin Delivery Improves Glycemia, Not Yet Perinatal Outcomes
★ Editor's Pick Analysis Women's Health / Reproductive Confirmatory Grade: Moderate
Also in Endocrinology / Diabetes / Obesity

Automated insulin delivery transforms diabetes management in pregnancy.

Indirect Network Meta-Analysis Ranks Cardiorenal Drugs in Diabetic CKD
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Low
Also in Nephrology, Cardiology

SGLT2 inhibitors show promise for renal outcomes in T2D-CKD.

SGLT2 versus DPP-4 Inhibitors: Modest Glycemic Edge, Consistent Weight Benefit
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Moderate

SGLT2 inhibitors excel in control but risk infections.

GLP-1 and SGLT-2 Therapies for Diabetes Prevention After Gestational Diabetes
Analysis Women's Health / Reproductive Hypothesis-generating Grade: Low
Also in Endocrinology / Diabetes / Obesity

Emerging therapies may prevent diabetes post-gestational diabetes.

Incretin Agonists as Rescue Therapy After Bariatric Surgery
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Low

Incretin receptor agonists enhance weight loss post-bariatric surgery.

Levothyroxine linked to short-term creatinine improvement in hypothyroid inpatients
Analysis Endocrinology / Diabetes / Obesity Hypothesis-generating Grade: Very Low
Also in Nephrology

Thyroid hormone therapy reverses renal dysfunction in hypothyroidism.

Outcome-Stratified Positioning of Incretin Therapies Across Cardiometabolic Phenotypes
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Low
Also in Nephrology

Incretin therapies expand treatment options for cardiometabolic conditions.

Once-Weekly Efsitora Hypoglycemia Duration Matches Daily Basal Insulins
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Low

Is once-weekly insulin as safe as daily doses for hypoglycemia?

Omnipod 5 sustains glycemic gains over 12 months in adults
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Low

The Omnipod 5 System enhances and sustains diabetes control long-term.

Pharmacist-Led Framework for Perioperative GLP-1 Agonist Risk Management
Analysis Perioperative / Anesthesia Hypothesis-generating Grade: Low
Also in Endocrinology / Diabetes / Obesity

Pharmacists can lead the safe perioperative management of GLP-1 receptor agonists.

Incretin Therapies Reshape Post-Bariatric Weight Recurrence Management
Analysis Endocrinology / Diabetes / Obesity Confirmatory Grade: Low

Incretin-based therapies redefine post-bariatric weight management.